Funding for this research was provided by:
Afya Bora Consortium (U91 HA06801)
European Commission (100448 LOCATOR TMA 2015 CDF – 1036)
Received: 14 October 2020
Accepted: 13 September 2021
First Online: 20 September 2021
: The study was approved by the IDI (Infectious Diseases Institute) scientific review committee, the Joint clinical research centre IRB (JC3517), and was registered with the National Council of Science and Technology and the office of the President of Uganda (HS175ES) in accordance with the Ugandan system of ethical approval. All participants provided written informed consent for the 1 year follow up interviews (which comprises this qualitative study) during enrolment into the main (LOCATOR) study. To maintain confidentiality, all participants were identified using codes throughout all documentation. Participants in this study have not been reported in any other COVID-19 related submissions by us or anyone else.
: Not applicable.
: The authors declare that there is no competing interests regarding this study.